http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180085701-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_441f7c6829d19d1f693aa6ad677f2e8d |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 |
filingDate | 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39689a6a08682b4f38ef4fd14d0db80d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a64891ae92921fd796c0ac3bdf54ef17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818f77d6c19dfdc54bc99bec68a536ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d55030b477611f8fed611982c743ae3 |
publicationDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20180085701-A |
titleOfInvention | Novel Derivatives of 2-Anilinopyrimidine and Composition Comprising the Same |
abstract | The present invention relates to a 2-anilinopyrimidine derivative represented by the following general formula (1) and a composition for preventing or treating cancer comprising the same as an active ingredient. The 2-anilinopyrimidine derivatives are excellent novel target substances The compositions of the present invention comprising the 2-anilinopyrimidine derivatives can be usefully used as a composition for treating cancer or a composition for preventing or improving cancer. [Chemical Formula 1] (In Formula 1, R 1 is 4- (C1 ~ C3) alkyl piperazine (4-C (C1 ~ C3 ) alkylpiperazine), 4- (C1 ~ C3) alkyl-piperidine (4- (C1 ~ C3) alkylpiperidine, piperidine, pyrrole, morpholine, pyrrolidine, thiomorpholine, indole, di (C1-C3) alkylamine di (C1-C3) alkylamine) and 4-halopiperidine, and R 2 is any one selected from the group consisting of morpholine, thiomorpholine, piperidine ), Di (C1-C3) alkylamine (di (C1-C3) alkylamine), cyclo (C3-C6) alkyl, and (C1-C4) alkoxy ). ≪ / RTI > |
priorityDate | 2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.